New York State Common Retirement Fund’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

New York State Common Retirement Fund’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-73,932	Closed	-$1.33M	–	3113
2017 Q4	$1.33M	Buy	73,932 +38,962	+111%	+$480K	﹤0.01%	1862
2017 Q3	$413K	Hold	34,970	–	–	﹤0.01%	2447
2017 Q2	$367K	Sell	34,970 -60,805	-63%	-$620K	﹤0.01%	2568
2017 Q1	$1.05M	Sell	95,775 -18,542	-16%	-$215K	﹤0.01%	2004
2016 Q4	$1.55M	Buy	114,317 +79,347	+227%	+$1.11M	﹤0.01%	1834
2016 Q3	$430K	Hold	34,970	–	–	﹤0.01%	2385
2016 Q2	$384K	Buy	34,970 +10,670	+44%	+$119K	﹤0.01%	2395
2016 Q1	$266K	Sell	24,300 -9,800	-29%	-$124K	﹤0.01%	2549
2015 Q4	$590K	Hold	34,100	–	–	﹤0.01%	2231
2015 Q3	$678K	Buy	34,100 +1,307	+4%	+$30K	﹤0.01%	2170
2015 Q2	$539K	Buy	+32,793	New	+$569K	﹤0.01%	2485

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

New York State Common Retirement Fund's SCMP Position: Q1 2018 in Review

New York State Common Retirement Fund sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 73,932 shares — an estimated $1.33M sold.

New York State Common Retirement Fund first reported a position in SCMP in Q2 2015 and held it in 11 quarters. The position peaked at $1.55M in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

New York State Common Retirement Fund reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
New York State Common Retirement Fund sold 73,932 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.33M.
New York State Common Retirement Fund first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
New York State Common Retirement Fund's Sucampo Pharmaceuticals, Inc. position peaked at $1.55M in Q4 2016.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on New York State Common Retirement Fund's 13F filing for Q1 2018, filed 10 May 2018.